Data Scientists are in demand on the job market: all 18 Helmholtz Centers have already advertised several positions calling for skills in AI methods in 2021.
Increasingly insensitive to standard drugs: Multi-resistant pathogens are spreading worldwide and even in the near future could threaten the safe treatment of deadly infectious diseases. However, the urgent demand for...
The Alexander von Humboldt Foundation has selected Prof Claus-Michael Lehr as a scout within the Henriette Herz Programme.This award allows him to select three young scientific talents from abroad who will work at HIPS...
The oral cavity germ Fusobacterium nucleatum is known to speed up the growth of human carcinomas, for example in the intestine or breast. In a joint study, the Helmholtz Institute for RNA-based Infection Research...
Immunosuppressed patients often cannot build up good protection after a vaccination because the necessary cells of the immune system function less well or are not present at all. This has been studied especially in the...
Dr Chantal Bader, postdoc in the Department of Microbial Natural Products at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), has been awarded a grant from the Hans-and-Ruth-Giessen-Foundation on 29...
The human recombinant anti-SARS-CoV-2 antibody COR-101 was developed in close cooperation of Technische Universität Braunschweig, the Helmholtz Centre for Infection Research (HZI) and the biotech company YUMAB GmbH in...
Welche Faktoren sind verantwortlich dafür, dass einige Menschen nach einer Infektion mit dem Coronavirus SARS-CoV-2 schwer erkranken, während andere nur leichte oder gar keine Symptome entwickeln? Dieser Frage gehen...
NFDI4Microbiota is set to become part of Germany’s national research data infrastructure (NFDI). In May 2021, a panel of experts recommended that the consortium should receive NFDI funding – and now the Joint Science...